Gene · 8324
Papers1,967
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,967
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The implications of alternative pre-mRNA splicing in cell signal transduction. | Exp Mol Med | 2023 | 37009804 | PubTator, text mining | PubMed |
| N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms. | Front Immunol | 2023 | 36999016 | PubTator, text mining | PubMed |
| HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer. | Mol Cancer | 2023 | 36997931 | PubTator, text mining | PubMed |
| mRNA translational specialization by RBPMS presets the competence for cardiac commitment in hESCs. | Sci Adv | 2023 | 36989351 | PubTator, text mining | PubMed |
| The Roles of Secreted Wnt Ligands in Cancer. | Int J Mol Sci | 2023 | 36982422 | PubTator, text mining | PubMed |
| Association of DNA Promoter Methylation and BRAF Mutation in Thyroid Cancer. | Curr Oncol | 2023 | 36975440 | PubTator, text mining | PubMed |
| WNT16b promotes the proliferation and self-renewal of human limbal epithelial stem/progenitor cells via activating the calcium/calcineurin A/NFATC2 pathway. | Cell Prolif | 2023 | 36974338 | PubTator, text mining | PubMed |
Effects of thermal stress and mechanistic target of rapamycin and wingless-type mouse mammary tumor virus integration site family pathways on the proliferation and differentiation of satellite cells derived from the breast muscle of different chicken lines. | Poult Sci | 2023 | 36948037 | PubTator, text mining | PubMed |
| Discovery of Drug-Responsive Phenomic Alteration-Related Driver Genes in the Treatment of Coronary Heart Disease. | Pharmgenomics Pers Med | 2023 | 36945217 | PubTator, text mining | PubMed |
| Developing a non-invasive diagnostic model for pediatric Crohn's disease using RNA-seq analysis. | Front Genet | 2023 | 36936436 | PubTator, text mining | PubMed |
| circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling. | J Exp Clin Cancer Res | 2023 | 36932454 | PubTator, text mining | PubMed |
| Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy. | Front Immunol | 2023 | 36926345 | PubTator, text mining | PubMed |
| Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients. | Front Pharmacol | 2023 | 36925640 | PubTator, text mining | PubMed |
| Prognostic value of the immunohistochemical score based on four markers in head and neck squamous cell carcinoma. | Front Immunol | 2023 | 36911694 | PubTator, text mining | PubMed |
| Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer. | Oncol Lett | 2023 | 36909377 | PubTator, text mining | PubMed |
| ETC-159, an Upstream Wnt inhibitor, Induces Tumour Necrosis via Modulation of Angiogenesis in Osteosarcoma. | Int J Mol Sci | 2023 | 36902186 | PubTator, text mining | PubMed |
| CircDNAJC11 interacts with TAF15 to promote breast cancer progression via enhancing MAPK6 expression and activating the MAPK signaling pathway. | J Transl Med | 2023 | 36895010 | PubTator, text mining | PubMed |
| Biasing AlphaFold2 to predict GPCRs and kinases with user-defined functional or structural properties. | Front Mol Biosci | 2023 | 36876042 | PubTator, text mining | PubMed |
| Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers. | Front Immunol | 2023 | 36875073 | PubTator, text mining | PubMed |
| Circular RNAs: implications of signaling pathways and bioinformatics in human cancer. | Cancer Biol Med | 2023 | 36861443 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8324/papers?page=13